HIGHFDA DRUG

Specialty Process Labs Issues Recall for Subpotent Thyroid Drug

Specialty Process Labs recalled 58 grams of Thyroid, USP due to subpotency. The recall affects products distributed nationwide. Consumers should stop using the drug immediately and contact their healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 16, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 16, 2026
Hazard Level
HIGH
Brand
Specialty Process Labs
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Specialty Process Labs
Product type
Thyroid Medication
Model numbers
Lot #H22254-1XV, Exp. 01/31/2027
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 16, 2026

  2. Reported by FDA DRUG

    January 28, 2026

  3. RecallRadar source check

    February 4, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Subpotent Drug

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Specialty Process Labs LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Thyroid medications like Thyroid, USP are commonly used to treat hypothyroidism and other thyroid disorders. Patients rely on these medications to manage their thyroid hormone levels effectively.

Why This Is Dangerous

The product is classified as subpotent, meaning it does not contain the required strength to be effective for treatment. This can lead to insufficient hormone levels in patients who depend on it for their health.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients using this recalled medication may experience inadequate treatment, leading to potential health risks. Immediate action is necessary to switch to a safe alternative.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your medication packaging.
  2. Verify the expiration date for your product.
  3. Refer to the FDA recall notice for additional details.

Where to find product info

Lot numbers and expiration dates are usually printed on the product label or packaging.

What timeline to expect

Refund processing or replacement timelines may vary; expect approximately 4-6 weeks for resolution.

If the manufacturer is unresponsive

  • Document your communication attempts with Specialty Process Labs.
  • Consider contacting the FDA for assistance if the company does not respond.

How to prevent similar issues

  • Always check recall notices for medications regularly.
  • Consult with your healthcare provider about medication changes or alternatives.

Documentation advice

Keep records of your purchase, including receipts, and any correspondence with the manufacturer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves Thyroid, USP, Rx only, Net Wt: 0.50kg. The affected lot number is H22254-1XV, with an expiration date of January 31, 2027. The product was distributed nationwide.

Key Facts

  • Recall date: January 16, 2026
  • Report date: January 28, 2026
  • Classification: Class II
  • Quantity recalled: 58 grams

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #H22254-1XV
Exp. 01/31/2027
Affected States
ALL
Report Date
January 28, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more